Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 2 |
2016 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?
Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):42-50. doi: 10.1097/PAI.0000000000000151.
Appl Immunohistochem Mol Morphol. 2016.
PMID: 26200837
Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.
Nowsheen S, Cooper T, Stanley JA, Yang ES.
Nowsheen S, et al.
PLoS One. 2012;7(10):e46614. doi: 10.1371/journal.pone.0046614. Epub 2012 Oct 11.
PLoS One. 2012.
PMID: 23071597
Free PMC article.
Item in Clipboard
HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.
Nowsheen S, Cooper T, Bonner JA, LoBuglio AF, Yang ES.
Nowsheen S, et al.
Cancer Res. 2012 Sep 15;72(18):4796-806. doi: 10.1158/0008-5472.CAN-12-1287.
Cancer Res. 2012.
PMID: 22987487
Free PMC article.
Item in Clipboard
Cite
Cite